(Q43928679)

English

Less could be better: the case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia

scientific article published on 14 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

0 references

Less could be better: the case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Ayad A Hussein

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Haydar Frangoul

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

14 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Pediatric Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

326-327

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12088

21 January 2018

Favorable outcome with allogeneic hematopoietic stem cell transplantation in pediatric acquired aplastic anemia patients.

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12088

21 January 2018

Management of acquired aplastic anemia in children

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12088

21 January 2018

Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12088

21 January 2018

Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12088

21 January 2018

Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12088

21 January 2018

Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Ne

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12088

21 January 2018

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12088

21 January 2018

Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12088

21 January 2018

Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12088

21 January 2018

Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12088

21 January 2018

Identifiers

10.1111/PETR.12088

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43928679&oldid=2104451903"